Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Virol ; 77(3): 2124-33, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12525647

RESUMEN

The nef gene products encoded by human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus type 1 (SIV-1) increase viral loads in infected hosts and accelerate clinical progression to AIDS. Nef exhibits a spectrum of biological activities, including the ability to downregulate surface expression of CD4 and major histocompatibility complex (MHC) class I antigens, to alter the state of T-cell activation, and to enhance the infectivity of viral particles. To determine which of these in vitro functions most closely correlates with the pathogenic effects of Nef in vivo, we constructed recombinant HIV-1 NL4-3 viruses carrying mutations within the nef gene that selectively impair these functions. These mutant viruses were evaluated for pathogenic potential in severe combined immunodeficiency (SCID) mice implanted with human fetal thymus and liver (SCID-hu Thy/Liv mice), in which virus-mediated depletion of thymocytes is known to be Nef dependent. Disruption of the polyproline type II helix (Pxx)4 within Nef (required for binding of Hck and p21-activated kinase-like kinases, downregulation of MHC class I, and enhancement of HIV-1 infectivity in vitro but dispensable for CD4 downregulation) did not impair thymocyte depletion in virus-infected Thy/Liv human thymus implants. Conversely, three separate point mutations in Nef that compromised its ability to downregulate CD4 attenuated thymocyte depletion while not diminishing viral replication. These findings indicate that the functional ability of Nef to downregulate CD4 and not MHC class I downregulation, Hck or PAK binding, or (Pxx)4-associated enhancement of infectivity most closely correlates with Nef-mediated enhancement of HIV-1 pathogenicity in vivo. Nef-mediated CD4 downregulation merits consideration as a new target for the development of small-molecule inhibitors.


Asunto(s)
Antígenos CD4/análisis , Productos del Gen nef/fisiología , VIH-1/patogenicidad , Alelos , Animales , Antígenos CD4/fisiología , Línea Celular , Regulación hacia Abajo , Antígenos de Histocompatibilidad Clase I/análisis , Humanos , Ratones , Ratones SCID , Productos del Gen nef del Virus de la Inmunodeficiencia Humana
2.
J Immunol ; 168(1): 325-31, 2002 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-11751977

RESUMEN

The ability of HIV-1 to evade the host immune response leads to the establishment of chronic infection. HIV-1 has been reported to up-regulate MHC I molecules on the surface of thymocytes from HIV-1-infected thymus. We demonstrate in this study that HIV-1 up-regulates MHC I on both HIV-1-infected and uninfected thymocytes in a manner that is independent of Nef, proportional to viral replication, and entirely mediated by IFN-alpha. IL-3Ralpha+ type 2 predendritic cells (preDC2) resident in the thymic medulla secrete IFN-alpha, which acts on IFN-alphabetaR-expressing immature thymocytes to induce MHC I expression. Furthermore, thymic preDC2 are permissive for HIV-1 infection and positive for intracellular p24. These data demonstrate the ability of IFN-alpha secreted by preDC2 to induce MHC I up-regulation in the HIV-1-infected human thymus.


Asunto(s)
Células Dendríticas/inmunología , Infecciones por VIH/inmunología , VIH-1 , Antígenos de Histocompatibilidad Clase I/biosíntesis , Interferón-alfa/fisiología , Timo/virología , Animales , Células Dendríticas/metabolismo , Proteína p24 del Núcleo del VIH/biosíntesis , Infecciones por VIH/virología , VIH-1/genética , VIH-1/aislamiento & purificación , Humanos , Interferón-alfa/metabolismo , Interferón-alfa/farmacología , Subunidad alfa del Receptor de Interleucina-3 , Ratones , Ratones SCID , Técnicas de Cultivo de Órganos , ARN Viral/análisis , Receptores de Interleucina-3/análisis , Células Madre/inmunología , Células Madre/metabolismo , Linfocitos T/inmunología , Linfocitos T/virología , Timo/citología , Timo/inmunología , Regulación hacia Arriba
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA